| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051824 Contacting an area of the skin showing symptoms of the hyperproliferative skin disorder such as psoriasis with silver or other noble metals in a nanocrystalline form |
| 05/02/2002 | US20020051799 Glucosylated hydroxystilbene compounds for treating skin conditions |
| 05/02/2002 | US20020051771 Apoptotic entities for use in treatment of T-cell-mediated and inflammatory disorders |
| 05/02/2002 | US20020051760 Method for screening a substance having promoting activity on hair growth |
| 05/02/2002 | US20020051755 Composition comprising at least one self-tanning agent chosen from monocarbonyl and polycarbonyl compounds and a flavylium salt compound which is unsubstituted in position 3, for coloring the skin, and uses thereof |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201227A2 Use of flavonoids as immunomodulating or immunoprotecting agents in cosmetic and dermatological compositions |
| 05/02/2002 | EP1201136A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200593A2 The il-1l1 gene and polypeptide products |
| 05/02/2002 | EP1200587A2 Receptors and associated proteins |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200581A1 Truncated egf receptor |
| 05/02/2002 | EP1200435A1 Purine derivatives inhibitors of tyrosine protein kinase syk |
| 05/02/2002 | EP1200432A1 Amido spiropiperidines promote the release of growth hormone |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200399A1 Vitamin d3 analogs |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/02/2002 | EP1200106A1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200085A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 05/02/2002 | EP1200057A1 Colloidal composition for esthetic correction |
| 05/02/2002 | EP1200040A1 Two-component composition for cosmetic or pharmaceutical use |
| 05/02/2002 | EP1200039A2 Emulsifier-free finely dispersed water-in-oil-type systems |
| 05/02/2002 | EP1199955A2 Method for treating and preventing finger disorders |
| 05/02/2002 | EP1146875A4 Myt1 kinase inhibitors |
| 05/02/2002 | EP0931086B1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 05/02/2002 | EP0881896B1 Skin treatment with salicylic acid esters and retinoids |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 05/02/2002 | DE10052590A1 Verwendung von 2-Hydrazino-1,3-thiazolen als Antioxidantien Use of 2-hydrazino-1,3-thiazoles as antioxidants |
| 05/02/2002 | DE10052333A1 Neue Sulfooxybenzamide New Sulfooxybenzamide |
| 05/02/2002 | DE10049549A1 Inhibitor of the transcription factor IFR-1, useful for treating e.g. transplant rejection and autoimmune disease, reduces expression of CD40 |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2427024A1 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 05/02/2002 | CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis |
| 05/02/2002 | CA2426244A1 Lipid formulations for target delivery |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2425280A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2420164A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
| 05/01/2002 | CN1347408A Use of maduraphthalazine derivs. as inhibitors of pro-inflammatory cytokins |
| 05/01/2002 | CN1347398A Salts of asiatic and madecassic acid suitable for preparation of pharmaceutical and cosmetic compositions |
| 05/01/2002 | CN1347327A Methods for glucagon suppression |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1347324A Composition for treatment of psoriasis |
| 05/01/2002 | CN1347323A Chemical compounds |
| 05/01/2002 | CN1347322A Chemical compounds |
| 05/01/2002 | CN1347310A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1347309A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1347308A Skin care compositions contg. combination of skin care actives |
| 05/01/2002 | CN1346828A Dicyclic aromatic compound and use thereof in human or animal medicine and cosmetic process |
| 05/01/2002 | CN1346674A Wanpi ointment |
| 05/01/2002 | CN1346667A Exterior-applied medicine 'Xiaobaiwang' for treating leukoderma and its preparing process |
| 05/01/2002 | CN1346665A Exterior-applied medicine for treating acne |
| 05/01/2002 | CN1346663A Exterior-applied ointment for treating skin injury and its preparing process |
| 05/01/2002 | CN1346662A Exterior-applied ointment for treating skin injury accompanied with infection or durable ulcer and its preparing process |
| 05/01/2002 | CN1346657A Liquid medicine for treating brandy nose |
| 05/01/2002 | CN1346656A Cream for whitening skin and eliminating wrinkles |
| 05/01/2002 | CN1346652A Quick-acting mosquito-repellent antipruritic liquid and its preparing process |
| 05/01/2002 | CN1346646A Medicine and method for treating leukoderma |
| 05/01/2002 | CN1346645A Snuff pill for treating TB and ulcer |
| 05/01/2002 | CN1346641A Freezed dried centipede |
| 05/01/2002 | CN1346639A Process for preparing nutritive liquid from oviduct of female Chinese forest frog |
| 05/01/2002 | CN1346638A Granular medicine of coral powder and its application |
| 05/01/2002 | CN1083830C Substd. benzamidines, their production and their use as medicaments |
| 05/01/2002 | CN1083717C Extract from leaves of gingko biloba |
| 04/30/2002 | US6380408 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1α, 25-dihydroxy vitamin D3 |
| 04/30/2002 | US6380391 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380255 Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds |
| 04/30/2002 | US6380251 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380250 Therapy of ocular hypertension which comprises administering cyclopentane heptan(ene)oic acid or its 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives |
| 04/30/2002 | US6380236 Method of treating onychomycosis |
| 04/30/2002 | US6380218 For therapy of respiratory, allergic, and inflammatory disorders comprising asthma, chronic obstructive pulmonary disease, acute respiratory disease syndrome, pulmonary hypersensitivity, and allergic rhinitis in a mammal |
| 04/30/2002 | US6380196 Bronchial therapeutics, bronchial dilators |
| 04/30/2002 | US6380184 For increased production of wool, milk, and meat by treating animals with therapeutically effective amount of compound |
| 04/30/2002 | US6380179 Administering n-(1-methyl-1-(4-methoxyphenyl)ethyl)-3-oxo-4-aza-5alpha-andro st-1-ene-17beta-carbaxamide |
| 04/30/2002 | US6380168 Administering 3-o-.beta.-glucopyranosyl(1-6)-.beta.-d-glucopyranosyl indole, 2-s-.beta.-d-glucopyranosyl-3-o-.beta.-d-glucopyranosyl-2-merc aptoindole for increasing blood flow to skin |
| 04/30/2002 | US6379927 Retinoblastoma fusion proteins |
| 04/30/2002 | US6379716 Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions |
| 04/30/2002 | US6379702 Flexibility; contour conforming; applying to skins |
| 04/30/2002 | US6379696 Adjust absorption |
| 04/30/2002 | US6379695 Betamethasone- and hyaluronic acid-treated thin adhesive plaster for the treatment of psoriasis dermatitis and dermatosis |
| 04/30/2002 | US6379692 Water insoluble drug ; adjustment of ph with acid |
| 04/30/2002 | US6379678 Culture product; antiallergens |
| 04/30/2002 | CA2230307C Aquatic animal treatment method and composition containing cajeput oil |
| 04/30/2002 | CA2200771C New silicated salicylic acid derivatives with desquamative properties |
| 04/30/2002 | CA2194976C Wound healing agent |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/25/2002 | WO2002033100A2 Regulation of human adenylate cyclase, type iv |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032861A2 Orally active salts with tyrosine kinase activity |